Cargando…

KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers

KRAS encodes K-Ras proteins, which take part in the MAPK pathway. The expression level of KRAS is high in tumor patients. Our study compared KRAS expression levels between 33 kinds of tumor tissues. Additionally, we studied the association of KRAS expression levels with diagnostic and prognostic val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Da, Wang, Lizhuang, Chen, Zheng, Zhang, Lijun, Xu, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624065/ https://www.ncbi.nlm.nih.gov/pubmed/36330448 http://dx.doi.org/10.3389/fgene.2022.1024920

Ejemplares similares

RNA-Associated Co-expression Network Identifies Novel Biomarkers for Digestive System Cancer
por: Chen, Zheng, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer
por: Cui, Zhiwei, et al.
Publicado: (2022)

The Functional Effects of Key Driver KRAS Mutations on Gene Expression in Lung Cancer
por: Zhang, Jisong, et al.
Publicado: (2020)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

LINC00958 may be a new prognostic biomarker in various cancers: A meta-analysis and bioinformatics analysis
por: Zhang, Helin, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Zhou, Lei, et al.
Publicado: (2022)

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022)

PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
por: Wang, Chenyu, et al.
Publicado: (2022)

CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer
por: Wang, Jianxin, et al.
Publicado: (2020)

Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response
por: Filipów, Samantha, et al.
Publicado: (2019)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer
por: Wu, Zhenzhen, et al.
Publicado: (2022)

RPP30 is a novel diagnostic and prognostic biomarker for gastric cancer
por: Kan, Ying, et al.
Publicado: (2022)

Identification of Potential Prognostic Biomarkers Associated With Macrophage M2 Infiltration in Gastric Cancer
por: Liu, Baohong, et al.
Publicado: (2022)

Comprehensive Analysis to Identify SPP1 as a Prognostic Biomarker in Cervical Cancer
por: Zhao, Kaidi, et al.
Publicado: (2022)

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers
por: Dai, Jiali, et al.
Publicado: (2023)

The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer
por: Chen, Biqing, et al.
Publicado: (2023)

Limitations of Explainability for Established Prognostic Biomarkers of Prostate Cancer
por: Manjang, Kalifa, et al.
Publicado: (2021)

SEC23A Is an Independent Prognostic Biomarker in Bladder Cancer Correlated With MAPK Signaling
por: Zeng, Bin, et al.
Publicado: (2021)

INHBA is a Prognostic Biomarker and Correlated With Immune Cell Infiltration in Cervical Cancer
por: Zhao, Kaidi, et al.
Publicado: (2022)

Identifying Potential Biomarkers of Prognostic Value in Colorectal Cancer via Tumor Microenvironment Data Mining
por: Li, Lei, et al.
Publicado: (2022)

Identification of Potential Prognostic Biomarker for Predicting Survival in Multiple Myeloma Using Bioinformatics Analysis and Experiments
por: Zhou, Jian, et al.
Publicado: (2021)

Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors
por: Eid, Refaat A., et al.
Publicado: (2023)

Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
por: Zocche, David M., et al.
Publicado: (2015)

MICA (∗)012:01 Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer
por: Ding, Weifeng, et al.
Publicado: (2020)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)

BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer
por: Zhang, Shiyu, et al.
Publicado: (2022)

TGFβ2 is a Prognostic Biomarker for Gastric Cancer and is Associated With Methylation and Immunotherapy Responses
por: Han, Bangling, et al.
Publicado: (2022)

PER1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Ovarian Cancer
por: Chen, Mali, et al.
Publicado: (2021)

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
por: Wang, Huihuan, et al.
Publicado: (2021)

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
por: Birkeland, E, et al.
Publicado: (2012)

A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer
por: Fan, Shuaishuai, et al.
Publicado: (2021)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

ATP6AP1 is a potential prognostic biomarker and is associated with iron metabolism in breast cancer
por: Tian, Ye, et al.
Publicado: (2022)

Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
por: Li, Yang, et al.
Publicado: (2021)

Identification of GGT5 as a Novel Prognostic Biomarker for Gastric Cancer and its Correlation With Immune Cell Infiltration
por: Wang, Yuli, et al.
Publicado: (2022)

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker
por: Dong, Qiguan, et al.
Publicado: (2022)

Cancer stemness-associated LINC02475 serves as a novel biomarker for diagnosis and prognosis prediction of hepatocellular carcinoma
por: Lin, Xian, et al.
Publicado: (2022)

CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eps5sspvo4k2215ldpg2h7sc3j